In the treatment of RA, anti-TNF therapy was found to increase the risk of cancer and severe infections [79], while anti-TNF therapy for Crohn’s disease has been reported to be correlated with a significantly higher risk of lymphoma [80]. The gene discussed is TNF; the disease is rheumatoid arthritis.